Back to search
FDAFDA · Food and drugs·Recall number D-0535-2026

Primidone Tablets, USP, 250 mg, 100-count bottle, RX only, Manufactured by: Lannett Company, Inc., Marketed by: GSMS, Incorporated, Camarillo, CA 93012. NDC 51407-638-01

Published May 27, 2026 · Recall initiated: April 27, 2026

Summary

FDA records drug Class III recall D-0535-2026, published May 27, 2026 and initiated April 27, 2026. Recalling firm: Golden State Medical Supply Inc.; Status: Ongoing; Reported quantity: 1,620 bottles; Lot: Lot #: GS067909, Exp 4/30/2028; GS068646, Exp 8/31/2026. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.

What to do

Voluntary: Firm initiated · Letter

Get an email if PRIMIDONE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
PRIMIDONE
Manufacturer
Golden State Medical Supply Inc.
Distributor
USA Nationwide
Lot
Lot #: GS067909, Exp 4/30/2028; GS068646, Exp 8/31/2026
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Primidone Tablets, USP, 250 mg, 100-count bottle, RX only, Manufactured by: Lannett Company, Inc., Marketed by: GSMS, Incorporated, Camarillo, CA 93012. NDC 51407-638-01 recalled?

Yes. FDA published recall D-0535-2026 on May 27, 2026. Reported hazard: Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: PRIMIDONE.